WO2009009431A3 - Mipol1-etv1 gene rearrangements - Google Patents

Mipol1-etv1 gene rearrangements Download PDF

Info

Publication number
WO2009009431A3
WO2009009431A3 PCT/US2008/069201 US2008069201W WO2009009431A3 WO 2009009431 A3 WO2009009431 A3 WO 2009009431A3 US 2008069201 W US2008069201 W US 2008069201W WO 2009009431 A3 WO2009009431 A3 WO 2009009431A3
Authority
WO
WIPO (PCT)
Prior art keywords
mipol1
gene rearrangements
etv1 gene
etv1
rearrangements
Prior art date
Application number
PCT/US2008/069201
Other languages
French (fr)
Other versions
WO2009009431A2 (en
Inventor
Arul M Chinnaiyan
Scott Tomlins
Saravana Mohan Dhanasekaran
Original Assignee
Univ Michigan
Arul M Chinnaiyan
Scott Tomlins
Saravana Mohan Dhanasekaran
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan, Arul M Chinnaiyan, Scott Tomlins, Saravana Mohan Dhanasekaran filed Critical Univ Michigan
Priority to US12/667,819 priority Critical patent/US9303291B2/en
Priority to CA2692793A priority patent/CA2692793C/en
Priority to EP08826146A priority patent/EP2171094B1/en
Priority to ES08826146T priority patent/ES2376509T3/en
Priority to AU2008275303A priority patent/AU2008275303B2/en
Priority to JP2010516161A priority patent/JP5433572B2/en
Priority to AT08826146T priority patent/ATE533861T1/en
Publication of WO2009009431A2 publication Critical patent/WO2009009431A2/en
Publication of WO2009009431A3 publication Critical patent/WO2009009431A3/en
Priority to US15/084,721 priority patent/US9719143B2/en
Priority to US15/639,583 priority patent/US10167517B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

Compositions and methods associated with recurrent MIPOL1-ETV1 genetic rearrangements that are useful for cancer diagnosis and therapy are disclosed.
PCT/US2008/069201 2007-07-06 2008-07-03 Mipol1-etv1 gene rearrangements WO2009009431A2 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
US12/667,819 US9303291B2 (en) 2007-07-06 2008-07-03 MIPOL1-ETV1 gene rearrangements
CA2692793A CA2692793C (en) 2007-07-06 2008-07-03 Mipol1-etv1 gene rearrangements
EP08826146A EP2171094B1 (en) 2007-07-06 2008-07-03 Mipol1-etv1 gene rearrangements
ES08826146T ES2376509T3 (en) 2007-07-06 2008-07-03 REPORTS OF GENES MIPOL 1-ETV1.
AU2008275303A AU2008275303B2 (en) 2007-07-06 2008-07-03 MIPOL1-ETV1 gene rearrangements
JP2010516161A JP5433572B2 (en) 2007-07-06 2008-07-03 MIPOL1-ETV1 gene rearrangement
AT08826146T ATE533861T1 (en) 2007-07-06 2008-07-03 MIPOL1-ETV1 GENE ARRANGEMENTS
US15/084,721 US9719143B2 (en) 2007-07-06 2016-03-30 MIPOL1-ETV1 gene rearrangements
US15/639,583 US10167517B2 (en) 2007-07-06 2017-06-30 MIPOL1-ETV1 gene rearrangements

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95862907P 2007-07-06 2007-07-06
US60/958,629 2007-07-06

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/667,819 A-371-Of-International US9303291B2 (en) 2007-07-06 2008-07-03 MIPOL1-ETV1 gene rearrangements
US15/084,721 Continuation US9719143B2 (en) 2007-07-06 2016-03-30 MIPOL1-ETV1 gene rearrangements

Publications (2)

Publication Number Publication Date
WO2009009431A2 WO2009009431A2 (en) 2009-01-15
WO2009009431A3 true WO2009009431A3 (en) 2009-04-02

Family

ID=40225089

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/069201 WO2009009431A2 (en) 2007-07-06 2008-07-03 Mipol1-etv1 gene rearrangements

Country Status (8)

Country Link
US (3) US9303291B2 (en)
EP (1) EP2171094B1 (en)
JP (1) JP5433572B2 (en)
AT (1) ATE533861T1 (en)
AU (1) AU2008275303B2 (en)
CA (1) CA2692793C (en)
ES (1) ES2376509T3 (en)
WO (1) WO2009009431A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2905410A1 (en) 2013-03-15 2014-09-25 Abbott Molecular Inc. Systems and methods for detection of genomic copy number changes
FR3010530B1 (en) * 2013-09-11 2015-10-09 Univ Rouen METHOD OF DIAGNOSING MALIGNANT HEMOPATHIES AND KIT THEREFOR
US9994912B2 (en) 2014-07-03 2018-06-12 Abbott Molecular Inc. Materials and methods for assessing progression of prostate cancer
JP2024507210A (en) * 2021-02-17 2024-02-16 エーシーティー ジェノミックス （アイピー） リミテッド DNA fragment linkage detection method and its kit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007033187A2 (en) * 2005-09-12 2007-03-22 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer

Family Cites Families (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4109496A (en) 1977-12-20 1978-08-29 Norris Industries Trapped key mechanism
US4323546A (en) 1978-05-22 1982-04-06 Nuc Med Inc. Method and composition for cancer detection in humans
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4683203A (en) 1984-04-14 1987-07-28 Redco N.V. Immobilized enzymes, processes for preparing same, and use thereof
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
DE3785591T2 (en) 1986-01-10 1993-09-02 Amoco Corp COMPETITIVE HOMOGENEOUS TEST.
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US4968103A (en) 1988-07-22 1990-11-06 Photofinish Cosmetics Inc. Method of making a brush
US5225326A (en) 1988-08-31 1993-07-06 Research Development Foundation One step in situ hybridization assay
GB8901778D0 (en) 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
DK0408295T3 (en) 1989-07-11 1996-09-16 Gen Probe Inc Methods for amplifying nucleic acid sequences
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5614396A (en) 1990-06-14 1997-03-25 Baylor College Of Medicine Methods for the genetic modification of endogenous genes in animal cells by homologous recombination
US5455166A (en) 1991-01-31 1995-10-03 Becton, Dickinson And Company Strand displacement amplification
US5270184A (en) 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
US5545524A (en) 1991-12-04 1996-08-13 The Regents Of The University Of Michigan Compositions and methods for chromosome region-specific probes
EP0552108B1 (en) 1992-01-17 1999-11-10 Lakowicz, Joseph R. Energy transfer phase-modulation fluoro-immunoassay
DE69333969T2 (en) 1992-10-30 2006-09-14 The General Hospital Corp., Boston Interactive trap system for the isolation of proteins
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
JP3448090B2 (en) 1994-02-16 2003-09-16 浜松ホトニクス株式会社 Energy transfer detection method and apparatus
US20050214309A1 (en) * 1994-03-18 2005-09-29 Hinrichs Steven H Methods and compositions for modulating transcription factor activity
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
JP3189000B2 (en) 1994-12-01 2001-07-16 東ソー株式会社 Specific nucleic acid sequence detection method
US5856125A (en) 1995-06-05 1999-01-05 The United States Of America As Represented By The Department Of Health And Human Services ETS2 repressor factor (ERF) genetic locus and its products
US5710029A (en) 1995-06-07 1998-01-20 Gen-Probe Incorporated Methods for determining pre-amplification levels of a nucleic acid target sequence from post-amplification levels of product
US5854206A (en) 1995-08-25 1998-12-29 Corixa Corporation Compounds and methods for treatment and diagnosis of prostate cancer
US6121489A (en) 1996-03-05 2000-09-19 Trega Biosciences, Inc. Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein
WO1997033909A2 (en) 1996-03-15 1997-09-18 Corixa Corporation Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
EP0892808B1 (en) 1996-04-12 2008-05-14 PHRI Properties, Inc. Detection probes, kits and assays
EP0929814A1 (en) 1996-10-07 1999-07-21 Meat And Livestock Commission Assay for duroc muscle fibre type
US7125969B1 (en) 1996-11-27 2006-10-24 The Regents Of The University Of California ETS-related gene overexpressed in human breast and epithelial cancers
TR199902053T2 (en) 1997-02-25 2000-04-21 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use.
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6395278B1 (en) 1997-02-25 2002-05-28 Corixa Corporation Prostate specific fusion protein compositions
US6043033A (en) 1997-02-27 2000-03-28 Incyte Pharmaceuticals, Inc. Human prostate-associated protease
US20030103981A1 (en) 1997-02-27 2003-06-05 Incyte Genomics, Inc. Methods of use of a prostate-associated protease in the diagnosis and treatment of prostate cancer
US20020119531A1 (en) 1997-02-27 2002-08-29 Olga Bandman Prostate-associated protease antibody
ATE363652T1 (en) 1997-03-07 2007-06-15 Clare Chemical Res Inc FLUOROMETRIC DETECTION WITH VISIBLE LIGHT
US6080912A (en) 1997-03-20 2000-06-27 Wisconsin Alumni Research Foundation Methods for creating transgenic animals
WO1998045420A1 (en) 1997-04-10 1998-10-15 Diagnocure Inc. Pca3, pca3 genes, and methods of use
US6187799B1 (en) 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
JP2002517185A (en) 1998-06-01 2002-06-18 アジェンシス，インコーポレイテッド Tumor antigens useful for diagnosis and treatment of prostate and colon cancer
US7037667B1 (en) 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
EP1087985A1 (en) 1998-06-16 2001-04-04 The Regents of the University of California Exons 4 and 7 encode separate transactivating and chromatin localizing domains in esx
AU4839999A (en) 1998-06-29 2000-01-17 Myriad Genetics, Inc. Tmprss2 is a tumor suppressor
CA2333253C (en) 1998-07-02 2010-09-07 Gen-Probe Incorporated Molecular torches
KR20070112860A (en) 1998-07-14 2007-11-27 코릭사 코포레이션 An isolated immnogenic portion of the prostate tumor protein and methods for diagnosis of prostate cancer using the same
DE69939874D1 (en) 1998-09-02 2008-12-18 Diadexus Inc METHOD OF DIAGNOSIS, EVALUATION AND IMAGE DISPLAY OF VARIOUS CANCER DISORDERS
US6872811B1 (en) 1998-09-30 2005-03-29 Millennium Pharmaceuticals, Inc. HRPCa9 and HRPCa10 nucleic acids and polypeptides
WO2000018961A2 (en) 1998-09-30 2000-04-06 Millennium Pharmaceuticals, Inc. Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
US6573043B1 (en) 1998-10-07 2003-06-03 Genentech, Inc. Tissue analysis and kits therefor
WO2000023111A1 (en) 1998-10-19 2000-04-27 Diadexus Llc Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
US6828429B1 (en) 1999-03-26 2004-12-07 Henry M. Jackson Foundation For The Advancement Of Military Medicine Prostate-specific gene, PCGEM1, and the methods of using PCGEM1 to detect, treat, and prevent prostate cancer
US6303305B1 (en) 1999-03-30 2001-10-16 Roche Diagnostics, Gmbh Method for quantification of an analyte
AU4484400A (en) 1999-04-23 2000-11-10 University Of Washington Prostate-specific polynucleotides, polypeptides and their methods of use
EP1179093A1 (en) 1999-05-14 2002-02-13 Chiron Corporation Expression of ets-domain proteins in cancer
EP1055734B1 (en) 1999-05-24 2004-10-13 Tosoh Corporation Method for assaying ribonucleic acid
US20020168638A1 (en) 2000-01-24 2002-11-14 Robert Schlegel Compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
DE10004102A1 (en) 2000-01-31 2002-06-20 Metagen Pharmaceuticals Gmbh Nucleic acids differentially expressed between tumor and normal cells, useful for diagnosis or therapy of tumors and for screening active agents
AU2001241541A1 (en) 2000-02-17 2001-08-27 Millennium Predictive Medicine, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
WO2001088124A2 (en) 2000-05-16 2001-11-22 Ribozyme Pharmaceuticals, Inc. Method and reagent for the inhibition of erg
JP2004504068A (en) 2000-07-27 2004-02-12 ザ　オーストラリアン　ナショナル　ユニバーシティー Combinatorial probes and their uses
CA2423154A1 (en) 2000-09-21 2002-03-28 David Kenneth Dean Imidazole derivatives as raf kinase inhibitors
US7892730B2 (en) 2000-12-22 2011-02-22 Sagres Discovery, Inc. Compositions and methods for cancer
US6897024B2 (en) 2001-05-31 2005-05-24 Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
US20040009481A1 (en) 2001-06-11 2004-01-15 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of human prostate cancer
WO2003009814A2 (en) 2001-07-25 2003-02-06 Millennium Pharmaceuticals, Inc. Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
US6537811B1 (en) 2001-08-01 2003-03-25 Isis Pharmaceuticals, Inc. Antisense inhibition of SAP-1 expression
US7229774B2 (en) 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
ES2253533T3 (en) 2001-09-06 2006-06-01 Adnagen Ag PROCEDURE FOR QUALITATIVE AND / OR QUANTITATIVE DETECTION OF CELLS.
US6949342B2 (en) 2001-12-21 2005-09-27 Whitehead Institute For Biomedical Research Prostate cancer diagnosis and outcome prediction by expression analysis
AU2003289716A1 (en) 2002-09-12 2004-04-30 Incyte Corporation Molecules for diagnostics and therapeutics
US7790867B2 (en) 2002-12-05 2010-09-07 Rosetta Genomics Inc. Vaccinia virus-related nucleic acids and microRNA
US20050282170A1 (en) 2003-02-07 2005-12-22 Diagnocure Inc. Method to detect prostate cancer in a sample
AU2004213432A1 (en) 2003-02-14 2004-09-02 Sagres Discovery, Inc. Novel therapeutic targets in cancer
US20070275915A1 (en) 2003-04-15 2007-11-29 Cell Genesys, Inc. Tmprss2 Regulatory Sequences and Uses Thereof
AU2004235747B2 (en) 2003-05-01 2009-05-28 Gen-Probe Incorporated Oligonucleotides comprising a molecular switch
WO2004097358A2 (en) 2003-05-02 2004-11-11 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2)
JP2007516693A (en) * 2003-06-09 2007-06-28 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン Compositions and methods for the treatment and diagnosis of cancer
WO2004113571A2 (en) 2003-06-26 2004-12-29 Exonhit Therapeutics Sa Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis
CA2432365A1 (en) 2003-06-30 2004-12-30 Jack A. Schalken Specific method of prostate cancer detection based on pca3, and kits therefore
WO2005007090A2 (en) 2003-07-03 2005-01-27 President And Fellows Of Harvard College Inhibitors of the map kinase pathway
WO2005007830A2 (en) 2003-07-14 2005-01-27 Mayo Foundation For Medical Education And Research Methods and compositions for diagnosis, staging and prognosis of prostate cancer
ATE451477T1 (en) 2003-09-05 2009-12-15 Univ Jefferson DIAGNOSIS AND MONITORING OF HEPATOCELLULAR CARCINOMA
JP5009787B2 (en) 2004-05-07 2012-08-22 ザ・ヘンリー・エム・ジャクソン・ファンデイション・フォー・ジ・アドヴァンスメント・オヴ・ミリタリー・メディシン、インコーポレイテッド A method for diagnosing or treating prostate cancer using the ERG gene alone or in combination with other genes that are overexpressed or underexpressed in prostate cancer
CN101018874A (en) 2004-08-13 2007-08-15 千年药品公司 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
EP1975242B1 (en) 2004-08-27 2011-03-02 Gen-Probe Incorporated Single-primer nucleic acid amplification methods
US20060275794A1 (en) 2005-03-07 2006-12-07 Invitrogen Corporation Collections of matched biological reagents and methods for identifying matched reagents
US7638278B2 (en) 2005-05-13 2009-12-29 The Board Of Trustees Of The Leland Stanford Junior University Markers of DNA copy number alteration for improved prognostication in prostate cancer
US9957569B2 (en) 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
WO2008063769A2 (en) 2006-10-10 2008-05-29 The Henry M.Jackson Foundation For The Advancement Of Military Medicine, Inc. Prostate cancer-specific alterations in erg gene expression and detection and treatment methods based on those alterations
CA2814246A1 (en) 2007-07-06 2009-01-15 The Regents Of The University Of Michigan Solute carrier family 45 member 3 (slc45a3) and erg family gene fusions in prostate cancer
JPWO2009044899A1 (en) 2007-10-03 2011-02-17 協和発酵キリン株式会社 Nucleic acids that control cell growth
WO2010096660A2 (en) 2009-02-19 2010-08-26 Cornell University Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
WO2011034906A2 (en) 2009-09-17 2011-03-24 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007033187A2 (en) * 2005-09-12 2007-03-22 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
KAMNASARAN DEEPAK ET AL: "Rearrangement in the PITX2 and MIPOL1 genes in a patient with a t(4;14) chromosome.", EUROPEAN JOURNAL OF HUMAN GENETICS : EJHG APR 2003, vol. 11, no. 4, April 2003 (2003-04-01), pages 315 - 324, XP007906798, ISSN: 1018-4813 *
KUMAR-SINHA CHANDAN ET AL: "Evidence of recurrent gene fusions in common epithelial tumors.", TRENDS IN MOLECULAR MEDICINE NOV 2006, vol. 12, no. 11, November 2006 (2006-11-01), pages 529 - 536, XP005718619, ISSN: 1471-4914 *
KUMAR-SINHA CHANDAN ET AL: "Recurrent gene fusions in prostate cancer.", NATURE REVIEWS. CANCER JUL 2008, vol. 8, no. 7, July 2008 (2008-07-01), pages 497 - 511, XP007906800, ISSN: 1474-1768 *
LAXMAN BHARATHI ET AL: "Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.", NEOPLASIA (NEW YORK, N.Y.) OCT 2006, vol. 8, no. 10, October 2006 (2006-10-01), pages 885 - 888, XP007906803, ISSN: 1476-5586 *
MEHRA ROHIT ET AL: "Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer.", MODERN PATHOLOGY : AN OFFICIAL JOURNAL OF THE UNITED STATES AND CANADIAN ACADEMY OF PATHOLOGY, INC MAY 2007, vol. 20, no. 5, May 2007 (2007-05-01), pages 538 - 544, XP007906804, ISSN: 0893-3952 *
NAM ROBERT K ET AL: "Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.", CANCER BIOLOGY & THERAPY JAN 2007, vol. 6, no. 1, January 2007 (2007-01-01), pages 40 - 45, XP009110689, ISSN: 1538-4047 *
PERNER SVEN ET AL: "TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.", THE AMERICAN JOURNAL OF SURGICAL PATHOLOGY JUN 2007, vol. 31, no. 6, June 2007 (2007-06-01), pages 882 - 888, XP009110691, ISSN: 0147-5185 *
TOMLINS SCOTT A ET AL: "Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.", NATURE 2 AUG 2007, vol. 448, no. 7153, 2 August 2007 (2007-08-02), pages 595 - 599, XP007906797, ISSN: 1476-4687 *
TOMLINS SCOTT A ET AL: "Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, US, WASHINGTON, DC, vol. 310, no. 5748, 28 October 2005 (2005-10-28), pages 644 - 648, XP002464140, ISSN: 0036-8075 *
TOMLINS SCOTT A ET AL: "TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.", CANCER RESEARCH 1 APR 2006, vol. 66, no. 7, 1 April 2006 (2006-04-01), pages 3396 - 3400, XP007906805, ISSN: 0008-5472 *

Also Published As

Publication number Publication date
AU2008275303A1 (en) 2009-01-15
EP2171094A2 (en) 2010-04-07
US9303291B2 (en) 2016-04-05
US20110028336A1 (en) 2011-02-03
US20160208343A1 (en) 2016-07-21
AU2008275303B2 (en) 2012-05-03
JP2010532668A (en) 2010-10-14
EP2171094B1 (en) 2011-11-16
US9719143B2 (en) 2017-08-01
ATE533861T1 (en) 2011-12-15
US20170327901A1 (en) 2017-11-16
CA2692793A1 (en) 2009-01-15
US10167517B2 (en) 2019-01-01
ES2376509T3 (en) 2012-03-14
WO2009009431A2 (en) 2009-01-15
JP5433572B2 (en) 2014-03-05
CA2692793C (en) 2014-05-20

Similar Documents

Publication Publication Date Title
WO2007134210A3 (en) Methods and compositions for the diagnosis and treatment of cancer
AU2016204376A1 (en) MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer
GB2447796C (en) Iodonitrobenzamide formulations for cancer and viral diseases.
WO2008103761A9 (en) Methods and compositions for cancer diagnosis and treatment based on nucleic acid methylation
WO2008091908A3 (en) Human cancer stem cells
WO2009076676A3 (en) Compositions and methods for producing isoprene
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
WO2009108860A3 (en) Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders
WO2008097543A8 (en) Gene methylation in cancer diagnosis
WO2009111643A3 (en) Microrna markers for recurrence of colorectal cancer
EP2684894A3 (en) Identification of tumor-associated markers for diagnosis and therapy
EP2068618A4 (en) Compositions and methods for cancer gene discovery
GB0519405D0 (en) Cancer therapy prognosis and target
EP2198021A4 (en) Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis
WO2008120098A3 (en) Peptide prodrugs
WO2007081751A9 (en) Compositions and methods for the treatment of cancer
WO2009015037A3 (en) 5-pyridinone substituted indazoles
EP2210942A4 (en) Gene associated with liver cancer, and method for determination of the risk of acquiring liver cancer
AU2008285554A8 (en) Ezrin assay method for the in vitro diagnosis of colorectal cancer
IL198354A0 (en) Genetic variations associated with tumors
WO2009009431A3 (en) Mipol1-etv1 gene rearrangements
WO2008069976A3 (en) Compounds and methods for enzyme-mediated tumor imaging and therapy
WO2009089102A3 (en) Identification and characterization of pregnancy- associated genetic signatures and use thereof for diagnosis and treatment of breast cancer
WO2008103431A3 (en) Dnai - liposomes
WO2008011482A3 (en) Methods and compositions for the diagnosis and treatment of cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08826146

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2692793

Country of ref document: CA

Ref document number: 2010516161

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008826146

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2008275303

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2008275303

Country of ref document: AU

Date of ref document: 20080703

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 12667819

Country of ref document: US